JPMorgan Chase Financial Co. LLC Files 424B2 Prospectus
| Field | Detail |
|---|---|
| Company | Jpmorgan Chase Financial Co. LLC |
| Form Type | 424B2 |
| Filed Date | Mar 24, 2026 |
| Risk Level | low |
| Pages | 15 |
| Reading Time | 18 min |
| Key Dollar Amounts | $4,981,000, $25.125, $54, $109, $1,000 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: debt-offering, prospectus, capital-raise, financial-services
Related Tickers: JPM
TL;DR
**JPM Financial Co. just filed a 424B2, likely issuing new debt under their existing shelf registration.**
AI Summary
JPMorgan Chase Financial Co. LLC, a subsidiary of JPMorgan Chase & Co., filed a 424B2 prospectus on March 24, 2026, related to a previously filed registration statement (File No. 333-270004-01). This filing indicates that JPMorgan Chase Financial Co. LLC is offering securities, likely debt, under an existing shelf registration. For investors, this means JPMorgan Chase Financial Co. LLC is raising capital, which could be used for general corporate purposes, potentially impacting future earnings or expansion plans, and signals ongoing financial activity within the JPMorgan Chase ecosystem.
Why It Matters
This filing indicates JPMorgan Chase Financial Co. LLC is actively raising capital, which could influence the parent company's financial health and strategic initiatives.
Risk Assessment
Risk Level: low — This is a routine prospectus filing for an established financial institution, indicating a standard capital-raising activity rather than an immediate high-risk event.
Analyst Insight
Investors should monitor subsequent filings or news from JPMorgan Chase Financial Co. LLC for details on the specific terms (e.g., interest rates, maturity dates) of the securities being offered, as this could impact the parent company's debt profile and cost of capital.
Key Numbers
- 0001665650 — CIK for JPMorgan Chase Financial Co. LLC (Unique identifier for the filing entity)
- 0000019617 — CIK for JPMorgan Chase & Co (Unique identifier for the parent company)
- 2026-03-24 — Filing Date (Date the 424B2 prospectus was filed)
Key Players & Entities
- JPMorgan Chase Financial Co. LLC (company) — Filer of the 424B2 prospectus
- JPMorgan Chase & Co (company) — Parent company of the filer
- March 24, 2026 (date) — Filing date of the 424B2
- 333-270004-01 (dollar_amount) — File number for JPMorgan Chase Financial Co. LLC's registration statement
- 333-270004 (dollar_amount) — File number for JPMorgan Chase & Co's registration statement
Forward-Looking Statements
- JPMorgan Chase Financial Co. LLC will successfully raise capital through the offering described in this prospectus. (JPMorgan Chase Financial Co. LLC) — high confidence, target: 2026-12-31
FAQ
What is the purpose of this 424B2 filing by JPMorgan Chase Financial Co. LLC?
The 424B2 filing is a prospectus supplement, typically used to offer securities under an existing shelf registration statement. In this case, it relates to the registration statement with File No. 333-270004-01, indicating JPMorgan Chase Financial Co. LLC is likely issuing new securities to raise capital.
When was this 424B2 filing submitted to the SEC?
This 424B2 filing was submitted and accepted by the SEC on March 24, 2026, at 16:46:18.
What is the relationship between JPMorgan Chase Financial Co. LLC and JPMorgan Chase & Co. based on this filing?
JPMorgan Chase Financial Co. LLC (CIK: 0001665650) is listed as a filer, and JPMorgan Chase & Co (CIK: 0000019617) is also listed as a filer with a related registration statement (File No. 333-270004), indicating that JPMorgan Chase Financial Co. LLC is a subsidiary or related entity operating under the broader JPMorgan Chase corporate structure.
What is the SIC code for both JPMorgan Chase Financial Co. LLC and JPMorgan Chase & Co.?
Both JPMorgan Chase Financial Co. LLC and JPMorgan Chase & Co. share the SIC code 6021, which corresponds to 'National Commercial Banks'.
What is the mailing address for JPMorgan Chase Financial Co. LLC?
The mailing address for JPMorgan Chase Financial Co. LLC is 383 MADISON AVENUE FLOOR 21 NEW YORK NY 10179, which is also listed as its business address.
Filing Stats: 4,607 words · 18 min read · ~15 pages · Grade level 12.2 · Accepted 2026-03-24 16:46:18
Key Financial Figures
- $4,981,000 — ”) Aggregate principal amount: $4,981,000 Early redemption: If, on any determi
- $25.125 — l pay a contingent quarterly payment of $25.125 (2.5125% of the stated principal amount
- $54 — d be zero. Downside threshold level: $54.76, which is equal to 50% of the initia
- $109 — ial stock price Initial stock price: $109.52, which was the closing price of the
- $1,000 — stock price Stated principal amount: $1,000 per security Issue price: $1,000 per
- $1,000.00 — ns Proceeds to issuer Per security $1,000.00 $17.50 (2) $977.50 $5.00 (3) Tota
- $17.50 — s to issuer Per security $1,000.00 $17.50 (2) $977.50 $5.00 (3) Total $4,9
- $977.50 — Per security $1,000.00 $17.50 (2) $977.50 $5.00 (3) Total $4,981,000.00 $1
- $5.00 — rity $1,000.00 $17.50 (2) $977.50 $5.00 (3) Total $4,981,000.00 $112,072.5
- $4,981,000.00 — 7.50 (2) $977.50 $5.00 (3) Total $4,981,000.00 $112,072.50 $4,868,927.50 (1) See &
- $112,072.50 — 50 $5.00 (3) Total $4,981,000.00 $112,072.50 $4,868,927.50 (1) See “Additio
- $4,868,927.50 — ) Total $4,981,000.00 $112,072.50 $4,868,927.50 (1) See “Additional Information
- $964.40 — the securities on the pricing date was $964.40 per $1,000 stated principal amount secu
- $100.00 — ty Hypothetical initial stock price: $100.00 Hypothetical downside threshold level
- $50 — Hypothetical downside threshold level: $50.00, which is 50% of the hypothetical in
Filing Documents
- ea0283240-01_424b2.htm (424B2) — 201KB
- ea028324001_ex-filingfees.htm (EX-FILING FEES) — 4KB
- image_001.jpg (GRAPHIC) — 47KB
- image_002.jpg (GRAPHIC) — 30KB
- image_003.jpg (GRAPHIC) — 21KB
- 0001213900-26-033590.txt ( ) — 431KB
- ea028324001_ex-filingfees_htm.xml (XML) — 2KB
Risk Factors
Risk Factors The following is a non-exhaustive list of certain key risk factors for investors in the securities. For further discussion of these and other risks, you should read the sections entitled “Risk Factors” of the accompanying prospectus supplement and the accompanying product supplement and in Annex A to the accompanying prospectus addendum. We urge you to consult your investment, legal, tax, accounting and other advisers in connection with your investment in the securities. The securities do not guarantee the return of any principal and your investment in the securities may result in a loss. The terms of the securities differ from those of ordinary debt securities in that the securities do not guarantee the return of any of the principal amount at maturity. Instead, if the securities have not been automatically redeemed prior to maturity and if the final stock price is less than the downside threshold level, you will be exposed to the decline in the closing price of the underlying stock, as compared to the initial stock price, on a 1-to-1 basis and you will receive for each security that you hold at maturity a cash payment equal to the stated principal amount times the stock performance factor. In this case, your payment at maturity will be less than 50% of the stated principal amount and could be zero. You will not receive any contingent quarterly payment for any quarterly period if the closing price of the underlying stock on the relevant determination date is less than the downside threshold level. The terms of the securities differ from those of ordinary debt securities in that the securities do not guarantee the payment of regular interest. Instead, a contingent quarterly payment will be made with respect to a quarterly period only if the closing price of the underlying stock on the relevant determination date is greater than or equal to the downside threshold level. If the closing price of the underlying stock is below the downside t